We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients who use social media to plan cosmetic procedures will now access more reliable information thanks to a landmark new initiative.
As with any medicine, the MHRA will keep the safety and effectiveness of teplizumab under close review.
Latest data shows an increase in travel-associated chikungunya cases compared to the same period last year
Baroness Amos has been selected to lead the independent investigation into NHS maternity and neonatal care to drive urgent improvements to care and safety.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about zuranolone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about 3 growth hormone agonists.
From 2026, driving theory tests will include new CPR questions and, for the first time, questions about defibrillators to boost cardiac arrest survival.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the consideration of ganaxolone.
New Market Exploration by Dstl/DMS through DASA seeks innovative technical solutions that could be used to model or monitor conflict wounds.
The latest heat-health alert (HHA) issued by UKHSA and the Met Office for all regions of England.
Thousands of new jobs will be unlocked across the healthcare sector to make sure there are enough jobs for every newly qualified nurse and midwife in England.
WHO recognition affirms MHRA’s commitment to regulatory excellence, innovation and global collaboration
UKHSA warns public to be alert to botulism following adverse reactions to cosmetic procedures involving botulinum toxin.
The UK NSC is currently consulting on adult screening for dementia and newborn screening for severe combined immunodeficiency (SCID)
The microscopic bacteria living in women’s bodies could be a powerful tool for personalised, non-invasive treatment and earlier diagnosis.
Professor Susan Hopkins is appointed as the new Chief Executive Officer of the UK Health Security Agency (UKHSA).
Infected Blood Compensation Authority's update that was circulated on 6 August 2025
Under a joint information sharing agreement, pharmaceutical companies will be invited to register early with the MHRA and NICE to allow parallel decision making over licencing and value.
Updates on regulatory reform and plans to support innovation.
New measures to crack down on cowboy cosmetic procedures will be introduced by the government.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).